Scleroderma Care and Research, Vol. 4, No. 1, Autumn 2006

"Scleroderma Care and Research" Journal

The Scleroderma Clinical Trials Consortium (SCTC) is a charitable nonprofit organization dedicated to finding better treatments for scleroderma. Member institutions of the SCTC have set up joint clinical trials, with funding from organizations such as the Scleroderma Foundation, the U.S. Food and Drug Administration (FDA), and the National Institutes of Health (NIH).

The SCTC publishes "Scleroderma Care and Research," a quarterly journal of health issues related to scleroderma.

You can read these publications in PDF format (see below). You will need Adobe Acrobat Reader. If you do not have it, you can download it free now.

The Scleroderma Foundation is one of the supporters of this publication.

Volume 4, Number 1

• This issue includes the abstracts that were presented at "The 9th International Workshop on Scleroderma Research"

Volume 3, Number 2

• Health-Related Quality of Life: A Primer with a Focus on Scleroderma, Dinesh Khanna, M.D.
• Pulmonary Arterial Hypertension in Systemic Sclerosis: Risk Factors and Diagnosis,
  Virginia Steen, M.D.

Volume 3, Number 1

• High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Treatment of Severe Systemic Sclerosis
• New Therapies for Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

Volume 2, Number 2

• Consensus Statement: Core Variables in the Assessment of the Patient with Systemic Sclerosis
• Eighth International Workshop on Scleroderma Research Bridges Basic and Clinical Research

Volume 2, Number 1

• Diagnostic and Management Preferences for Lung Disease in Scleroderma: Results of Survey of Rheumatologists
• Erectile Dysfunction in Men with Scleroderma

Volume 1, Number 2

• The Genetics of Scleroderma: What Every Rheumatologist Should Know
• Digital Ulceration and Critical Digital Ischemia in Scleroderma

Volume 1, Number 1

• Premier Issue: Lung Involvement in Scleroderma